These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8712635)

  • 21. Treatment of lethal midline granuloma type nasal T-cell lymphoma.
    Sakata K; Hareyama M; Ohuchi A; Sido M; Nagakura H; Morita K; Harabuchi Y; Kataura A
    Acta Oncol; 1997; 36(3):307-11. PubMed ID: 9208902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
    Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
    Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary non-Hodgkin's lymphoma of the nose and paranasal sinuses: a case report.
    Murthy VS; Murthy CN; Belagavi CS; Chandra S; Munishwara GB
    Indian J Pathol Microbiol; 2003 Jan; 46(1):82-4. PubMed ID: 15027735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiocentric T-cell lymphoma presenting as lethal midline granuloma.
    Lee PY; Freeman NJ; Khorsand J; Weinstock MA
    Int J Dermatol; 1997 Jun; 36(6):419-27. PubMed ID: 9248885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant lymphomas and related conditions involving nasal cavity and paranasal sinuses: a clinicopathologic study of forty-two cases with emphasis on prognostic factors.
    Maeda H; Aozasa K; Tsujimura T; Sasaki R; Yoshida J; Matsunaga T
    Eur J Surg Oncol; 1988 Feb; 14(1):9-15. PubMed ID: 3345857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic significance of serum levels of soluble intercellular adhesion molecules-1 in patients with primary extranodal non-Hodgkin lymphomas.
    Lei KI; Johnson PJ
    Cancer; 2000 Sep; 89(6):1387-95. PubMed ID: 11002235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54).
    Horst E; Meijer CJ; Radaszkiewicz T; Ossekoppele GJ; Van Krieken JH; Pals ST
    Leukemia; 1990 Aug; 4(8):595-9. PubMed ID: 1974938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Malignant granuloma of the face and angiocentric T-cell lymphoma. A review of the literature apropos of a case].
    Vanrenterghem L; Joly B; de Cordoue X; Montreuil G; Palliez TM; Maillot E; Leleu C; Riviere O; Bosq J
    Rev Stomatol Chir Maxillofac; 1994; 95(1):17-21. PubMed ID: 8153547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of intercellular adhesion molecule-3 (ICAM-3/CD50) in malignant lymphoproliferative disorders and solid tumors.
    Terol MJ; Cid MC; López-Guillermo A; Juan M; Yagüe J; Miralles A; Vilella R; Vives J; Cardesa A; Montserrat E; Campo E
    Tissue Antigens; 1996 Oct; 48(4 Pt 1):271-7. PubMed ID: 8946680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-Hodgkin's lymphomas of the nose and paranasal sinuses in the pediatric population.
    Bumpous JM; Martin DS; Curran P; Stith JA
    Ann Otol Rhinol Laryngol; 1994 Apr; 103(4 Pt 1):294-300. PubMed ID: 8154771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum levels of soluble ICAM-1 in non-Hodgkin's lymphomas correlate with tumour burden, disease activity and other prognostic markers.
    Christiansen I; Gidlof C; Kälkner K M; Hagberg H; Bennmarker H; Tötterman T
    Br J Haematol; 1996 Mar; 92(3):639-46. PubMed ID: 8616029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A; Berg R
    Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels and differential expression of intercellular adhesion molecule-1 in childhood leukemia and malignant lymphoma: prognostic importance and relationship with survival.
    Tacyildiz N; Yavuz G; Gozdasoglu S; Unal E; Ertem U; Duru F; Ikinciogullari A; Babacan E; Ensari A; Okcuoglu-Cavdar A
    Pediatr Hematol Oncol; 1999; 16(2):149-58. PubMed ID: 10100275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
    Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Primary extranodal non-Hodgkin's lymphoma of the head and neck].
    Festini G; Longaro F; Volpe C
    Recenti Prog Med; 1997 Apr; 88(4):169-72. PubMed ID: 9206813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A rare case of malignant lymphoma of the nasal cavity and paranasal sinuses].
    Teresińska E; Szpiech A; Margański J; Kowalczyk J
    Otolaryngol Pol; 2001; 55(2):199-201. PubMed ID: 11494739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Midline malignant reticulosis. A clinicopathologic entity.
    Fechner RE; Lamppin DW
    Arch Otolaryngol; 1972 May; 95(5):467-76. PubMed ID: 5067476
    [No Abstract]   [Full Text] [Related]  

  • 38. [Non-Hodgkin lymphoma in the head and neck region].
    Torjussen W; Holt GL
    Tidsskr Nor Laegeforen; 2002 Apr; 122(11):1098-100. PubMed ID: 12043052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative analysis of lymphomas involving Waldeyer's ring and the nasal cavity and paranasal sinuses.
    Robbins KT; Kong JS; Fuller LM; Goepfert H
    J Otolaryngol; 1985 Feb; 14(1):7-13. PubMed ID: 4068097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.